4-5628622-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_147127.5(EVC2):​c.1823G>A​(p.Arg608His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,613,972 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R608C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 5 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:4B:5

Conservation

PhyloP100: 0.347

Publications

7 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068377852).
BP6
Variant 4-5628622-C-T is Benign according to our data. Variant chr4-5628622-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 281122.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.1823G>Ap.Arg608His
missense
Exon 12 of 22NP_667338.3
EVC2
NM_001166136.2
c.1583G>Ap.Arg528His
missense
Exon 12 of 22NP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.1823G>Ap.Arg608His
missense
Exon 12 of 22ENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.1583G>Ap.Arg528His
missense
Exon 12 of 22ENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.1583G>A
non_coding_transcript_exon
Exon 12 of 23ENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.00125
AC:
190
AN:
151986
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000984
Gnomad ASJ
AF:
0.0130
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000378
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00171
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00150
AC:
377
AN:
251480
AF XY:
0.00149
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.0115
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.00183
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00179
AC:
2618
AN:
1461868
Hom.:
5
Cov.:
31
AF XY:
0.00178
AC XY:
1293
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000827
AC:
37
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0126
AC:
330
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.000356
AC:
19
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.00191
AC:
2121
AN:
1111994
Other (OTH)
AF:
0.00152
AC:
92
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
151
302
452
603
754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00125
AC:
190
AN:
152104
Hom.:
2
Cov.:
32
AF XY:
0.00117
AC XY:
87
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41496
American (AMR)
AF:
0.000982
AC:
15
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
45
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000378
AC:
4
AN:
10580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00171
AC:
116
AN:
67986
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00183
Hom.:
3
Bravo
AF:
0.00117
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00143
AC:
174
EpiCase
AF:
0.00147
EpiControl
AF:
0.00178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
3
not provided (5)
1
1
-
Type IV short rib polydactyly syndrome (2)
-
1
-
Ellis-van Creveld syndrome (1)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)
-
-
1
EVC2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.022
Eigen_PC
Benign
0.0019
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.0068
T
MetaSVM
Uncertain
-0.25
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
0.35
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.63
N
REVEL
Benign
0.18
Sift
Benign
0.48
T
Sift4G
Benign
0.21
T
Polyphen
0.64
P
Vest4
0.49
MVP
0.83
MPC
0.18
ClinPred
0.034
T
GERP RS
4.0
Varity_R
0.052
gMVP
0.10
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145693546; hg19: chr4-5630349; COSMIC: COSV60396977; API